ANDA 77699, held by Hikma Intl Pharms. Mefloquine Hydrochloride.
As of Nov 16, 2026, ANDA 77699 (Mefloquine Hydrochloride), held by Hikma Intl Pharms, was first approved by FDA on Apr 21, 2010, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 21, 2010 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Mefloquine Hydrochloride250MG · tablet;oral | Mefloquine Hydrochloride | Discontinued |
| Oct 11, 2016 | Supplement 5Labeling · Standard review | Approved | None posted |
| Oct 6, 2016 | Supplement 6Labeling · Standard review | Approved | None posted |
| Aug 16, 2011 | Supplement 1Labeling | Approved | None posted |
| Apr 21, 2010 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters